NCT00991926View on ClinicalTrials.gov

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

February 28, 2009

Conditions

Obesity

Interventions

DRUG

Orlistat

orlistat (Xenical, Roche, UK)120 mg tid

OTHER

normo-caloric diet

Food intake and dietary history were assessed by a skilled dietitian who used a computer-assisted interview (Winfood 1.5, Medimatica srl, Martinsicuro, Italy)

All Listed Sponsors

lead

Federico II University

OTHER

NCT00991926 - Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat | Biotech Hunter | Biotech Hunter